Investors with a lot of money to spend have taken a bearish stance on Hims & Hers Health HIMS.
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with HIMS, it often means somebody knows something is about to happen.
So how do we know what these investors just did?
Today, Benzinga's options scanner spotted 15 uncommon options trades for Hims & Hers Health.
This isn't normal.
The overall sentiment of these big-money traders is split between 33% bullish and 46%, bearish.
Out of all of the special options we uncovered, 6 are puts, for a total amount of $497,058, and 9 are calls, for a total amount of $499,670.
Predicted Price Range
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $12.0 to $30.0 for Hims & Hers Health over the recent three months.
Analyzing Volume & Open Interest
In terms of liquidity and interest, the mean open interest for Hims & Hers Health options trades today is 1573.69 with a total volume of 13,503.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Hims & Hers Health's big money trades within a strike price range of $12.0 to $30.0 over the last 30 days.
Hims & Hers Health Option Volume And Open Interest Over Last 30 Days
Significant Options Trades Detected:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| HIMS | PUT | SWEEP | BULLISH | 06/21/24 | $14.2 | $13.7 | $13.7 | $30.00 | $227.4K | 190 | 190 |
| HIMS | CALL | TRADE | NEUTRAL | 01/17/25 | $2.75 | $2.65 | $2.7 | $18.00 | $91.2K | 119 | 520 |
| HIMS | CALL | SWEEP | BULLISH | 11/15/24 | $1.65 | $1.6 | $1.66 | $20.00 | $82.6K | 474 | 503 |
| HIMS | PUT | TRADE | BULLISH | 06/21/24 | $0.8 | $0.75 | $0.76 | $15.50 | $76.0K | 345 | 1.0K |
| HIMS | CALL | TRADE | BEARISH | 06/14/24 | $0.75 | $0.65 | $0.65 | $17.00 | $65.0K | 277 | 1.0K |
About Hims & Hers Health
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more.
In light of the recent options history for Hims & Hers Health, it's now appropriate to focus on the company itself. We aim to explore its current performance.
Present Market Standing of Hims & Hers Health
- Currently trading with a volume of 8,609,543, the HIMS's price is down by -2.6%, now at $15.75.
- RSI readings suggest the stock is currently may be approaching overbought.
- Anticipated earnings release is in 74 days.
Professional Analyst Ratings for Hims & Hers Health
In the last month, 4 experts released ratings on this stock with an average target price of $18.25.
- In a cautious move, an analyst from Citigroup downgraded its rating to Neutral, setting a price target of $20.
- Consistent in their evaluation, an analyst from Deutsche Bank keeps a Hold rating on Hims & Hers Health with a target price of $16.
- An analyst from Piper Sandler persists with their Neutral rating on Hims & Hers Health, maintaining a target price of $13.
- Consistent in their evaluation, an analyst from Canaccord Genuity keeps a Buy rating on Hims & Hers Health with a target price of $24.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Hims & Hers Health options trades with real-time alerts from Benzinga Pro.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
